Matches in Library of Congress for { <http://lccn.loc.gov/2012405814> ?p ?o. }
Showing items 1 to 35 of
35
with 100 items per page.
- 2012405814 contributor B12576017.
- 2012405814 contributor B12576018.
- 2012405814 created "c2010.".
- 2012405814 date "2010".
- 2012405814 date "c2010.".
- 2012405814 dateCopyrighted "c2010.".
- 2012405814 description "Background. The public health perspective on medical countermeasure development, acquisition, and use -- ; The FDA perspective on the countermeasures enterprise : moving forward -- Government procurement of science -- Partners in a single mission, diverse concerns and challenges. The growing threat of bioweapons -- Gaps and barriers to international collaboration -- Issues for federal agencies engaged in countermeasures development -- Challenges facing the innovative biopharmaceutical industry -- Research infrastructure and resources -- Liability -- End users : challenges for public health and providers -- Examples of successful countermeasures development and deployment. Features of successful government countermeasures efforts -- Countermeasures development in industry -- Partnerships and alternative business models. Venture philanthropy and orphan product development models -- Pharmaceutical shared-risk approaches -- Planning for failure -- Open innovation business strategies -- Public-private partnerships -- Independent third-party facilitation of collaboration -- Strategic investor model -- Engaging industry. Incentives : Push vs. Pull -- Incentives not needed? : making a strong business case -- New paradigms, strategies, a nd tactics for enhancing the countermeasures development enterprise. Outsourcing program management -- Government as a strategic partner -- Platform technologies -- Revised PHEMCE implementation plan -- Existing regulatory tools and approaches that can be applied to advance countermeasures development. Opportunities for accelerating approval of medical countermeasures : evolving the regulatory framework -- The way forward : themes from the workshop -- References -- Workshop agenda -- Registered workshop attendees -- Case studies of HHS chemical, biological, radiological, and nuclear medical countermeasure development programs, executive summary -- Synthesis of business models and economic and market incentives for vaccines and therapeutics.".
- 2012405814 description "Includes bibliographical references.".
- 2012405814 extent "xiv, 179 p. :".
- 2012405814 hasFormat "Also issued online.".
- 2012405814 identifier "0309150248".
- 2012405814 identifier "9780309150248".
- 2012405814 identifier catalog.php?record_id=12856.
- 2012405814 identifier NBK50754.
- 2012405814 identifier br.fcgi?book=nap12856.
- 2012405814 isFormatOf "Also issued online.".
- 2012405814 issued "2010".
- 2012405814 issued "c2010.".
- 2012405814 language "eng".
- 2012405814 publisher "Washington, D.C. : National Academies Press,".
- 2012405814 relation "Also issued online.".
- 2012405814 spatial "United States".
- 2012405814 subject "2010 I-631".
- 2012405814 subject "363.34/525 23".
- 2012405814 subject "Disaster Medicine United States Congresses.".
- 2012405814 subject "Emergencies United States Congresses.".
- 2012405814 subject "Emergency management Congresses.".
- 2012405814 subject "Emergency management United States Planning Congresses.".
- 2012405814 subject "Public Health United States Congresses.".
- 2012405814 subject "Public health United States Congresses.".
- 2012405814 subject "RA645.5 .P828 2010".
- 2012405814 subject "WA 295".
- 2012405814 tableOfContents "Background. The public health perspective on medical countermeasure development, acquisition, and use -- ; The FDA perspective on the countermeasures enterprise : moving forward -- Government procurement of science -- Partners in a single mission, diverse concerns and challenges. The growing threat of bioweapons -- Gaps and barriers to international collaboration -- Issues for federal agencies engaged in countermeasures development -- Challenges facing the innovative biopharmaceutical industry -- Research infrastructure and resources -- Liability -- End users : challenges for public health and providers -- Examples of successful countermeasures development and deployment. Features of successful government countermeasures efforts -- Countermeasures development in industry -- Partnerships and alternative business models. Venture philanthropy and orphan product development models -- Pharmaceutical shared-risk approaches -- Planning for failure -- Open innovation business strategies -- Public-private partnerships -- Independent third-party facilitation of collaboration -- Strategic investor model -- Engaging industry. Incentives : Push vs. Pull -- Incentives not needed? : making a strong business case -- New paradigms, strategies, a nd tactics for enhancing the countermeasures development enterprise. Outsourcing program management -- Government as a strategic partner -- Platform technologies -- Revised PHEMCE implementation plan -- Existing regulatory tools and approaches that can be applied to advance countermeasures development. Opportunities for accelerating approval of medical countermeasures : evolving the regulatory framework -- The way forward : themes from the workshop -- References -- Workshop agenda -- Registered workshop attendees -- Case studies of HHS chemical, biological, radiological, and nuclear medical countermeasure development programs, executive summary -- Synthesis of business models and economic and market incentives for vaccines and therapeutics.".
- 2012405814 title "The public health emergency medical countermeasures enterprise : innovative strategies to enhance products from discovery through approval : workshop summary / Theresa Wizemann, Clare Stroud, and Bruce M. Altevogt, rapporteurs ; Forum on Medical and Public Health Preparedness for Catastrophic Events ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies.".
- 2012405814 type "text".